P

Pfizer Portfolio holdings

AUM $239M
1-Year Est. Return 232.47%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+232.47%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$239M
AUM Growth
+$2.31M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
19
New
Increased
Reduced
Closed

Top Buys

1
+$1.06M

Top Sells

1
+$6.77M
2
+$5.86M
3
+$837K
4
ANTX icon
AN2 Therapeutics
ANTX
+$815K
5
ZURA icon
Zura Bio
ZURA
+$792K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORIC icon
1
Oric Pharmaceuticals
ORIC
$812M
$57.7M 24.14%
4,780,401
-595,943
ALLO icon
2
Allogene Therapeutics
ALLO
$708M
$49.8M 20.85%
22,032,040
ARVN icon
3
Arvinas
ARVN
$516M
$34.9M 14.63%
3,457,815
CELC icon
4
Celcuity
CELC
$4.46B
$31.3M 13.13%
295,652
-53,754
ZURA icon
5
Zura Bio
ZURA
$389M
$16.8M 7.05%
2,838,913
-131,109
WVE icon
6
Wave Life Sciences
WVE
$1.09B
$11.9M 5%
1,875,000
PYXS icon
7
Pyxis Oncology
PYXS
$108M
$9.21M 3.86%
7,032,770
CRBU icon
8
Caribou Biosciences
CRBU
$198M
$8.35M 3.5%
4,690,431
SPRO icon
9
Spero Therapeutics
SPRO
$162M
$5.5M 2.31%
2,362,348
BHVN icon
10
Biohaven
BHVN
$1.53B
$4.23M 1.77%
505,645
CRDF icon
11
Cardiff Oncology
CRDF
$95.7M
$3.74M 1.57%
2,411,575
ZNTL icon
12
Zentalis Pharmaceuticals
ZNTL
$281M
$2M 0.84%
953,834
NXTC icon
13
NextCure
NXTC
$12.3M
$1.54M 0.64%
153,354
-4,292
AGMB
14
AgomAb Therapeutics NV
AGMB
$581M
$814K 0.34%
+75,000
QTTB icon
15
Q32 Bio
QTTB
$214M
$737K 0.31%
101,618
-176,159
BOLT icon
16
Bolt Biotherapeutics
BOLT
$9.82M
$137K 0.06%
31,305
DNA icon
17
Ginkgo Bioworks
DNA
$570M
$17.4K 0.01%
2,928
SENS icon
18
Senseonics Holdings Inc
SENS
$359M
$14.2K 0.01%
2,171
ANTX icon
19
AN2 Therapeutics
ANTX
$147M
– –
-715,295